Yüklüyor......

Progress in Developing Virus-like Particle Influenza Vaccines

Recombinant vaccines based on virus-like particles (VLPs) or nanoparticles have been successful in their safety and efficacy in preclinical and clinical studies. The technology of expressing enveloped VLP vaccines has combined with molecular engineering of proteins in membrane-anchor and immunogenic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Expert Rev Vaccines
Asıl Yazarlar: Quan, Fu-Shi, Lee, Young-Tae, Kim, Ki-Hye, Kim, Min-Chul, Kang, Sang-Moo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5093318/
https://ncbi.nlm.nih.gov/pubmed/27058302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14760584.2016.1175942
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!